ConductScience.org, home

Paper42530482

A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies.

Li Y and 5 others. Stat Med, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies. Papers, record 42530482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42530482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Bayesian Optimal Adaptive Clinical Trial Design for Sequentially Integrated Therapies.
PubMed
Journal
Stat Med
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-25
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adaptive Clinical Trials as TopicMajor topic
Research DesignMajor topic
Bayes Theorem
Humans
Computer Simulation
Models, Statistical
Alcoholism

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5U24AA026969NIH HHSUnited StatesU24AA026969PubMedNIH RePORTER
R01 GM150808NIGMS NIH HHSUnited StatesR01GM150808PubMedNIH RePORTER
P30 CA082709NCI NIH HHSUnited StatesP30CA082709PubMedNIH RePORTER
5R01GM150808NIH HHSUnited StatesR01GM150808PubMedNIH RePORTER
U24 AA026969NIAAA NIH HHSUnited StatesU24AA026969PubMedNIH RePORTER
P30CA082709NIH HHSUnited StatesP30CA082709PubMedNIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130739965A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes.J Am Stat Assoc2018https://conductscience.org/library/papers/30739965PubMed
236161762A Bayesian phase I/II design to determine subgroup-specific optimal dose for immunotherapy sequentially combined with radiotherapy.Pharm Stat2023https://conductscience.org/library/papers/36161762PubMed
311172350A model to predict survival in patients with end-stage liver disease.Hepatology2001https://conductscience.org/library/papers/11172350PubMed
411460223MELD and PELD: application of survival models to liver allocation.Liver Transpl2001https://conductscience.org/library/papers/11460223PubMed
537721513SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials.Biometrics2023https://conductscience.org/library/papers/37721513PubMed
617763973A review of phase 2-3 clinical trial designs.Lifetime Data Anal2008https://conductscience.org/library/papers/17763973PubMed
738342441Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.J Hepatol2024https://conductscience.org/library/papers/38342441PubMed
822826199Optimal design of multi-arm multi-stage trials.Stat Med2012https://conductscience.org/library/papers/22826199PubMed
928589563BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints.Stat Med2017https://conductscience.org/library/papers/28589563PubMed
1021318084Bayesian Models and Decision Algorithms for Complex Early Phase Clinical Trials.Stat Sci2010https://conductscience.org/library/papers/21318084PubMed
1135363500
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation2022https://conductscience.org/library/papers/35363500PubMed
1230115921Alcoholic liver disease.Nat Rev Dis Primers2018https://conductscience.org/library/papers/30115921PubMed
1316281458Dynamic treatment regimes: practical design considerations.Clin Trials2004https://conductscience.org/library/papers/16281458PubMed
147980801Practical Bayesian guidelines for phase IIB clinical trials.Biometrics1994https://conductscience.org/library/papers/7980801PubMed
1538055648Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis.Hepatol Commun2023https://conductscience.org/library/papers/38055648PubMed
1628459138Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study.Hepatology2017https://conductscience.org/library/papers/28459138PubMed
1729199843Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness.Psychol Addict Behav2017https://conductscience.org/library/papers/29199843PubMed
1825901427Prednisolone or pentoxifylline for alcoholic hepatitis.N Engl J Med2015https://conductscience.org/library/papers/25901427PubMed
1925811018Adaptive clinical trial designs in oncology.Chin Clin Oncol2014https://conductscience.org/library/papers/25811018PubMed
209280033Bayesian interim analysis of phase II cancer clinical trials.Stat Med1997https://conductscience.org/library/papers/9280033PubMed

See all 49 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42804611Therapies for alcohol use disorder in alcohol-associated hepatitis clinical trials: Integrated trial design with a composite clinical outcome as the primary endpoint.Hepatology2026https://conductscience.org/library/papers/42804611

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42530482

GET https://conductscience.org/api/papers/v1/42530482/references?page=2